Tuesday, April 7, 2009

Definite Strategic Collaboration

BEIJING, April 6 /PRNewswire/ -- BioDuro announced today that they have entered into a strategic partnership with Roche to support discovery phase research efforts at Roche's global research sites. BioDuro will provide research services in the areas of discovery chemistry and biology, which can help to shorten (internal) drug discovery timelines. This agreement is an expansion of an existing relationship.
Roche has many years of experience in partnering with external companies to complement its internal drug discovery expertise with external services and innovation. After extensive evaluation of many companies, Roche selected BioDuro as a strategic partner for this effort.
"Presently, there is intense competition within the CRO industry for outsourcing and drug discovery services, and the expectation is that they will deliver problem solving skills and innovation in both chemistry and biology," commented Robert Goodnow, Ph.D., Roche's Global Head of Medicinal Chemistry Outsourcing. "We selected BioDuro due to their demonstrated excellent performance in synthetic chemistry and ability to deliver integrated medicinal chemistry services."
"BioDuro is pleased to build upon this existing collaboration and work closely with the experienced team at Roche to aid in the development of novel therapeutics. We care deeply about working on projects that will impact the quality of life worldwide and working with Roche ensures this outcome. Our partnership demonstrates the strength of our innovative, fully integrated R&D service platform, and is a true testament to the caliber of scientists that have joined our team," commented John Oyler, Chief Executive Officer and co-founder of BioDuro LLC.
About Roche
Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's bigges'/>"/>

SOURCE BioDuroCopyright©2009 PR Newswire.All rights reserved

No comments: